Dawnrays Pharmaceutical (Holdings) Ltd Sustainability Reports

Dawnrays Pharmaceutical (Holdings) Limited is an investment holding company principally engaged in the development, manufacture, and sale of non-patented pharmaceutical medicines, including cephalosporin antibiotics and various system-specific generic drugs.

Sector: Manufacturing

Country: Hong Kong

Exchange: Hong Kong Stock Exchange

FIGI: BBG001S8SSL4

18 reports from 2007 to 2025

• Dawnrays Pharmaceutical (Holdings) Ltd 2025 Annual Report
• Dawnrays Pharmaceutical (Holdings) Ltd 2025 Environmental, Social and Governance Report
• Dawnrays Pharmaceutical (Holdings) Ltd 2024 Annual Report
• Dawnrays Pharmaceutical (Holdings) Ltd 2024 Environmental, Social and Governance Report
• Dawnrays Pharmaceutical (Holdings) Ltd 2023 Annual Report